Ms Katherine Helm > Dechert LLP > New York, United States > Lawyer Profile

Dechert LLP
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
Katherine Helm photo

Work Department

Intellectual Property

Position

Partner

Career

Dr. Katherine A. (“Kassie”) Helm, Ph.D., represents clients in patent litigation and related intellectual property, antitrust, healthcare and international arbitration matters. Dr. Helm’s neuroscience background offers a unique perspective to innovator pharmaceutical, biotechnology and healthcare companies in all aspects of litigation, from pre-suit diligence through trial, appeal and full trials on remand.  She has represented life sciences companies in patent infringement, declaratory judgment, preliminary injunction and Hatch-Waxman actions, involving small and large molecules, as well as in pay-for-delay antitrust litigation, and in a variety of both federal and state complex commercial litigation and international arbitrations, involving joint ventures, licensing and drug development agreements.  Dr. Helm also has significant experience with concurrent Patent Office proceedings and global litigation including Inter Partes Reviews (IPRs), Post Grant Reviews (PGRs), Interferences and appeals, European Patent Office (EPO) Oppositions and appeals, as well as UK, French and other European patent revocation and infringement actions.

Education

  • Princeton University, A.B., 1999, cum laude, Sigma Xi
  • Johns Hopkins University, M.A., 2001
  • Johns Hopkins University, Ph.D., 2003, Full Scholarship, the Natural Sciences and Engineering Council of Canada
  • Fordham University School of Law, J.D., 2008, cum laude, Dean’s List, Parchomovsky-Siegelman Student Graduation Prize, Helen and Norman Burg Graduate Student Ethics Prize, Senior Articles Editor, Fordham Intellectual Property, Media & Entertainment Law Journal

Lawyer Rankings

United States > Healthcare > Life sciences

(Next Generation Partners)

Katherine HelmDechert LLP

Regarded by some clients as ‘easily the best’, Dechert LLP’s global life sciences practice often handles patent and IP litigations, contentious antitrust matters, and product liability related issues. Working with a host of start-ups and mature pharmaceutical and biotech companies, Andrea Reid co-heads the team from Boston, drawing on her expertise in IP strategy and prosecution. Based in New York, the ‘truly exceptional‘ fellow co-chair David S Rosenthal maintains a corporate finance and life sciences M&A focused practice. Rosenthal routinely advises public and private investment banks and venture capital firms on IPOs and CMPOs looking to invest in life sciences and medical device companies. Also based in New York, Katherine Helm notably acts for biotech and pharmaceutical companies in biologics patent disputes before the PTAB.

United States > Intellectual property > Patents: litigation (full coverage)

The intellectual property group at Dechert LLP works on international IP disputes including global pharma assets, with experience in numerous US district courts along with advising on cases internationally. Numerous members of the practice possess advanced degrees in scientific and technical backgrounds. Martin Black leads the national patent litigation team out of the firm’s Philadelphia office, alongside Austin-based Jeffrey B. Plies. Operating out of New York, Katherine Helm frequently represents innovator pharma and biotech companies, utilizing her neuroscience doctorate.